Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 185,896 | 171,223 | 274,527 | 353,361 | 433,508 |
| Marketable Securities | 242,179 | 233,967 | 211,875 | 153,851 | 110,724 |
| Receivables | 43,883 | 17,401 | 35,994 | 24,266 | 40,543 |
| Inventories | 43,067 | 31,015 | 29,315 | 24,530 | 20,764 |
| TOTAL | $524,415 | $474,059 | $573,399 | $564,466 | $621,694 |
| Non-Current Assets | |||||
| PPE Net | 26,881 | 28,277 | 29,052 | 30,670 | 30,933 |
| Investments And Advances | 97,643 | 171,621 | 146,057 | 108,841 | 96,162 |
| Other Non-Current Assets | 96,995 | 99,864 | 102,005 | 104,641 | 38,512 |
| TOTAL | $221,519 | $299,762 | $277,114 | $244,152 | $165,607 |
| Total Assets | $745,934 | $773,821 | $850,513 | $808,618 | $787,301 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 36,353 | 26,097 | 23,868 | 48,988 | 24,061 |
| Accrued Expenses | 203,299 | 172,599 | 151,346 | 147,801 | 119,781 |
| TOTAL | $255,374 | $225,497 | $209,316 | $232,764 | $167,047 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4,744 | 15,857 | 23,256 | 25,234 | 10,725 |
| Other Non-Current Liabilities | 127,652 | 132,410 | 133,714 | 143,138 | 56,297 |
| TOTAL | $312,545 | $319,211 | $296,134 | $296,003 | $229,981 |
| Total Liabilities | $567,919 | $544,708 | $505,450 | $528,767 | $397,028 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,732 | 3,720 | 3,708 | 3,705 | 3,685 |
| Common Shares | 933 | 929 | 927 | 926 | 921 |
| Retained earnings | -1,327,239 | -1,264,034 | -1,129,956 | -1,179,754 | -1,045,766 |
| Other shareholders' equity | 13,462 | 15,804 | 15,113 | 14,704 | 14,647 |
| TOTAL | $178,015 | $229,113 | $345,063 | $279,851 | $390,273 |
| Total Liabilities And Equity | $745,934 | $773,821 | $850,513 | $808,618 | $787,301 |